Recession-Proof Beverage Behemoth Set for Double-Digit Gains
Energy drinks are becoming more recession-proof as a consumer staple — Monster’s annual sales are a testament to that.
Read More
Author: Matthew Clark
Biotech IPO (Cancer Drug Maker) — Money & Markets Week Ahead
The index suffered a 254% drop from its high of 36.7 in February to its low of negative 56.6 in April.
The Bull & The Bear: A Deep Dive on 3 Health Care Stocks
At the end of 2019, the health care sector of the stock market lagged the S&P 500 Index by nearly 6%. But it’s making a comeback.
The Bull & The Bear: 1 Bullish Trend to Watch Now
Recently, a major index showed a trend that could lead to a broader bullish market on the horizon.
Aging Boomers Lead Health Care Surge — 2 Stocks to Buy
In 2019, the estimated revenue of the industry was nearly $2.5 trillion. Health care takes up nearly 20% of the gross domestic product (GDP) in the U.S.
Watchlist
